LB Equity Announces Investment in Standard Dose, First Platform Dedicated to Newly Legalized CBD-Based Products and Information
LB Equity (LBE), an investment firm focused on emerging brands in the beauty and personal care sectors, today announced an investment in Standard Dose.
LB Equity (‘LBE’), an investment firm focused on emerging brands in the
beauty and personal care sectors, today announced an investment in
Standard Dose. Standard Dose is a first-of-its-kind platform dedicated
to the pursuit of elevated wellness through natural healing products,
including education and sale of hemp-based Cannabinoid (‘CBD’) beauty
products. This is the first portfolio investment in LBE’s $50 million
‘LB Equity Emerging Growth’ Fund, which will be concentrating its
investments in the beauty, health and wellness, and sustainability
sectors, with an emphasis on emerging cannabis-based products and
companies.
CBD is derived from the cannabis plant and has been shown to have
significant medicinal benefits in the areas of, among other things,
anxiety, pain, inflammation, sleep issues, detox and skin care.
Hemp-based CBD contains little to no THC and is therefore
non-psychoactive. Hemp-based CBD compounds were made legal as part of
the 2018 Farm Bill, which was passed by the United States Congress and
signed into law on December 20, 2018.
“LBE is targeting the massive opportunity available at the intersection
of the rapidly growing cannabis industry and the many emerging brands
within the skincare, beauty and related personal care sectors,” said Jay
Lucas, Managing Partner of LB Equity. “With experienced executives from
both the finance and beauty industries, LBE is perfectly positioned to
leverage the transformational impact that these newly legalized
cannabis-based products will have on the beauty industry.”
Standard Dose has created a digital retail platform that will provide
content to educate consumers on all aspects of the CBD market, including
the restorative properties of CBD, current industry research, product
and dosage information and regulatory updates. The platform will also
sell a highly curated, well-vetted and tested selection of the most
effective and trusted hemp-derived CBD products available today,
starting with 37 distinct beauty and lifestyle consumer brands.
“Our goal at Standard Dose is to facilitate an honest conversation about
CBD and to help consumers gain clarity of an industry that, until now,
has been confusing and unregulated,” said Anthony Saniger, Founder and
CEO of Standard Dose. “We take the time to vet all of our products and
share information so that consumers can choose CBD products with
confidence. With the very recent legalization of CBD, we know that
interest in the industry and its products will skyrocket. Standard Dose
will be the go-to source for anyone interested in elevating their
lifestyle by tapping into the natural health benefits of CBD products.”
About LB Equity
LB Equity is led by Jay Lucas, a former partner at Bain & Company, Karen
Ballou, a highly experienced beauty industry professional (Redken and
Elizabeth Arden) and Jim Morrison, who served as President of L’Oreal
U.S. for nearly 10 years. The extended team consists of strategy and
investment professionals along with an advisory group of veteran
industry executives across core value creation disciplines. Prior to
Standard Dose and the latest Fund, LBE has completed investments in ten
additional beauty and personal care brands, including MD Complete,
Marula Pure Oil, Immunocologie and Blamtastic among others.
About Standard Dose
Standard Dose is a multibrand CBD retailer dedicated to the pursuit of
elevated wellness through natural healing practices. The
company’s digital retail platform is designed to help educate consumers
about all aspects of CBD and offers a curated range of more than 60
ingestible and topical natural remedies for anxiety, pain, inflammation,
detoxification and skincare. The company’s ingestible products include
vape pens, tinctures, olive oil, honey and beverages, and its topical
products range from healing creams and serums to transdermal patches.
Each product Standard Dose offers is sampled and tested to ensure that
it meets the highest standards of effectiveness, feel and experience.
These tests are further validated through product lab test results,
which are required for all brand partner submissions. Meeting legal
standards, every product Standard Dose offers is made with industrial
hemp that contains less than .3% THC.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190131005138/en/